More about

Apolipoprotein

News
January 17, 2025
3 min read
Save

Q&A: Coffee, tea may impact memory, cognition, motor function related to Alzheimer’s

Consumption of certain teas and coffee may have positive effects on neural network maintenance that could bode well for the prevention of symptoms indicative of Alzheimer’s disease, according to research published in Nutrients.

News
June 24, 2024
1 min read
Save

Apolipoprotein L1 kidney risk variants linked to post-transplant collapsing glomerulopathy

PHILADELPHIA — In patients with post-transplant collapsing glomerulopathy, a similar portion of donors had one or two apolipoprotein L1 kidney risk variants, whereas few had none.

News
May 02, 2024
2 min read
Save

Apolipoprotein L1 genotype may not be a major factor for kidney disease risk

Apolipoprotein L1 genotype may not be a major factor for future risk of kidney disease in middle-aged adults, according to data from a longitudinal cohort study.

News
March 18, 2024
2 min read
Save

Patients with higher apolipoprotein A-I levels at greater risk for giant cell arteritis

Patients who eventually developed giant cell arteritis demonstrated significantly higher levels of apolipoprotein A-I at baseline, according to population-based data published in Arthritis Research & Therapy.

News
June 09, 2023
3 min read
Save

Pegozafermin lowers high triglycerides, non-HDL and ApoB vs. placebo in small trial

Pegozafermin, a fibroblast growth factor 21 analog, reduced atherogenic particles in patients with severe hypertriglyceridemia and improved liver fat and insulin resistance compared with placebo, a speaker reported.

News
May 22, 2023
1 min read
Save

Top in cardiology: Alirocumab ruling; trials target lipoprotein(a)

A unanimous U.S. Supreme Court decision has allowed Regeneron and Sanofi to continue selling alirocumab after Amgen alleged they infringed two of its patents for PCSK9 inhibitor technology.

News
February 14, 2023
2 min read
Save

High-risk apolipoprotein L1 genotype correlates with kidney failure risk

Regardless of proteinuria, the presence of a high-risk apolipoprotein L1 genotype in patients with chronic kidney disease correlates with an increased risk of kidney failure, according to data published in Kidney Medicine.

News
November 07, 2022
2 min read
Save

Olpasiran cut Lp(a) levels by more than 95% in patients with atherosclerotic CVD

CHICAGO — Olpasiran, a small interfering RNA agent directed to the liver, yielded substantial and sustained reductions in lipoprotein(a) concentrations among patients with established atherosclerotic CVD in the phase 2 OCEAN(a)-DOSE study.

News
September 09, 2022
3 min read
Save

Obicetrapib decreases LDL, increases HDL in phase 2 trial

In a phase 2 trial, obicetrapib, an investigational cholesteryl ester transfer protein inhibitor, decreased LDL, non-HDL, lipoprotein(a) and apolipoprotein B and increased HDL at 8 weeks, researchers reported in Nature Medicine.

News
June 06, 2022
2 min read
Save

Lp(a), ApoB concentrations vary across Hispanic/Latino populations

In a cohort of more than 16,000 Hispanic/Latino Americans, there was heterogeneity in lipoprotein(a) and apolipoprotein B levels according to background, researchers reported at the National Lipid Association Scientific Sessions.

View more